Products
Therapeutic Areas
Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and mental health, including ADHD and schizophrenia.
Women's Health
Developing and commercializing therapies for women’s menopausal health concerns has been a cornerstone of Noven’s business since it was founded in 1987.
Mental Health
Noven’s flagship product in the mental health therapeutic category is DAYTRANA® (methylphenidate transdermal system), the first and only transdermal system approved for ADHD in children and adolescents ages 6-17.